Joshua E. Insler MD , Aaron E. Tipton MD , Faisal G. Bakaeen MD , Jules J. Bakhos MD , Penny L. Houghtaling MS , Eugene H. Blackstone MD , Eric E. Roselli MD , Edward G. Soltesz MD, MPH , Michael Z. Tong MD , Shinya Unai MD , Kenneth McCurry MD , Patrick Vargo MD , Kevin Hodges MD , Nicholas G. Smedira MD, MBA , Gösta B. Pettersson MD, PhD , Aaron Weiss MD, PhD , Marijan Koprivanac MD, MS , Haytham Elgharably MD , A. Marc Gillinov MD , Lars G. Svensson MD, PhD
{"title":"What determines outcomes in multivalve reoperations? Effect of patient and surgical complexity","authors":"Joshua E. Insler MD , Aaron E. Tipton MD , Faisal G. Bakaeen MD , Jules J. Bakhos MD , Penny L. Houghtaling MS , Eugene H. Blackstone MD , Eric E. Roselli MD , Edward G. Soltesz MD, MPH , Michael Z. Tong MD , Shinya Unai MD , Kenneth McCurry MD , Patrick Vargo MD , Kevin Hodges MD , Nicholas G. Smedira MD, MBA , Gösta B. Pettersson MD, PhD , Aaron Weiss MD, PhD , Marijan Koprivanac MD, MS , Haytham Elgharably MD , A. Marc Gillinov MD , Lars G. Svensson MD, PhD","doi":"10.1016/j.jtcvs.2023.12.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div><span>Patient characteristics, risks, and outcomes associated with reoperative multivalve cardiac surgery are poorly characterized. Effect of patient variables and surgical components of each </span>reoperation<span> were evaluated with regard to operative mortality.</span></div></div><div><h3>Methods</h3><div><span>From January 2008 to January 2022, 2324 patients with previous cardiac surgery underwent 2352 reoperations involving repair or replacement of multiple cardiac valves<span> at Cleveland Clinic. Mean age was 66 ± 14 years. Number of surgical components representing surgical complexity (valve procedures, aortic surgery, </span></span>coronary artery bypass grafting, and atrial fibrillation procedures) ranged from 2 to 6. Random forest for imbalanced data was used to identify risk factors for operative mortality.</div></div><div><h3>Results</h3><div><span>Surgery was elective in 1327 (56%), urgent in 1006 (43%), and emergency in 19 (0.8%). First-time reoperations were performed in 1796 (76%) and 556 (24%) had 2 or more previous operations. Isolated multivalve operations comprised 54% (1265) of cases; 1087 incorporated additional surgical components. Two valves were operated on in 80% (1889) of cases, 3 in 20% (461), and 4 in 0.09% (2). Operative mortality was 4.2% (98 out of 2352), with 1.7% (12 out of 704) for elective, isolated multivalve reoperations. For each added surgical component, operative mortality incrementally increased, from 2.4% for 2 components (24 out of 1009) to 17% for ≥5 (5 out of 30). Predictors of operative mortality included coronary artery bypass grafting, surgical urgency, cardiac, renal dysfunction, peripheral artery disease, </span>New York Heart Association functional class, and anemia.</div></div><div><h3>Conclusions</h3><div>Elective, isolated reoperative multivalve surgery can be performed with low mortality. Surgical complexity coupled with key physiologic factors can be used to inform surgical risk and decision making.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"168 6","pages":"Pages 1632-1642.e2"},"PeriodicalIF":4.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022522323011923","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Patient characteristics, risks, and outcomes associated with reoperative multivalve cardiac surgery are poorly characterized. Effect of patient variables and surgical components of each reoperation were evaluated with regard to operative mortality.
Methods
From January 2008 to January 2022, 2324 patients with previous cardiac surgery underwent 2352 reoperations involving repair or replacement of multiple cardiac valves at Cleveland Clinic. Mean age was 66 ± 14 years. Number of surgical components representing surgical complexity (valve procedures, aortic surgery, coronary artery bypass grafting, and atrial fibrillation procedures) ranged from 2 to 6. Random forest for imbalanced data was used to identify risk factors for operative mortality.
Results
Surgery was elective in 1327 (56%), urgent in 1006 (43%), and emergency in 19 (0.8%). First-time reoperations were performed in 1796 (76%) and 556 (24%) had 2 or more previous operations. Isolated multivalve operations comprised 54% (1265) of cases; 1087 incorporated additional surgical components. Two valves were operated on in 80% (1889) of cases, 3 in 20% (461), and 4 in 0.09% (2). Operative mortality was 4.2% (98 out of 2352), with 1.7% (12 out of 704) for elective, isolated multivalve reoperations. For each added surgical component, operative mortality incrementally increased, from 2.4% for 2 components (24 out of 1009) to 17% for ≥5 (5 out of 30). Predictors of operative mortality included coronary artery bypass grafting, surgical urgency, cardiac, renal dysfunction, peripheral artery disease, New York Heart Association functional class, and anemia.
Conclusions
Elective, isolated reoperative multivalve surgery can be performed with low mortality. Surgical complexity coupled with key physiologic factors can be used to inform surgical risk and decision making.
期刊介绍:
The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.